Jaguar Health, Inc. Profile Avatar - Palmy Investing

Jaguar Health, Inc.

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segment…

Biotechnology
US, San Francisco [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
Jaguar Health, Inc. can't present any analysts estimates at the moment detail analysis.
End of JAGX's Analysis
CIK: 1585608 CUSIP: 47010C607 ISIN: US47010C7065 LEI: - UEI: -
Secondary Listings
JAGX has no secondary listings inside our databases.